Research Summary
A botanical drug, also known as a phytomedicine or a phytopharmaceutical, refers to a drug or medicinal product that is derived from botanical sources, primarily plants or plant extracts. These drugs are developed and formulated using active ingredients obtained from plants, which may include leaves, flowers, stems, roots, or other plant parts. Botanical drugs have been used for centuries in traditional medicine systems, such as Ayurveda, Traditional Chinese Medicine (TCM), and Native American medicine. In recent years, there has been growing interest in the development of botanical drugs within the framework of modern medicine. To be classified as a botanical drug, a product must meet certain criteria and undergo a regulatory approval process. The specific requirements vary depending on the country or regulatory agency involved. In the United States, for example, the U.S. Food and Drug Administration (FDA) has established guidelines for the development, evaluation, and approval of botanical drugs under the category of botanical drug products (BDPs). Botanical drugs can be developed as single-ingredient formulations or as complex mixtures of various plant constituents. They may be used to treat a wide range of conditions, including but not limited to cardiovascular disorders, respiratory diseases, immune disorders, gastrointestinal issues, and skin conditions. It＇s important to note that while botanical drugs are derived from natural sources, they still undergo rigorous scientific and clinical evaluation to ensure safety, efficacy, and quality. This involves conducting preclinical studies, clinical trials, and adhering to good manufacturing practices to produce standardized and consistent products.
According to WENKH research statistics, the global Botanical Drug market size will reach 46,139 Million USD in 2025 and is projected to reach 65,183 Million USD by 2032, with a CAGR of 5.06% (2025-2032). Among them, the Asia-Pacific Botanical Drug market is undergoing rapid changes, reaching Million USD in 2025, accounting for approximately % of the global market share. It is projected to reach Million USD by 2032.
The global Botanical Drug market is highly competitive, with key market players including Buchang Pharmaceuticals, China TCM, Tsumura, Schwabe, Tong Ren Tang, Jumpcan Pharmaceutical, Guangzhou Baiyunshan Pharmaceutical, Yunnan Baiyao, Tasly Holding Group, Bionorica Se, Weleda, Taiji, Huarun 999, Kwangdong, GW Pharmaceuticals, etc. This report categorizes the competitive landscape of the global Botanical Drug market into three tiers based on annual revenue, with the top three market players holding approximately % of the total market share.
This report provides an in-depth analysis of the global Botanical Drug market, including market size, price trends, market status and future development prospects. It particularly focuses on the market share, product characteristics, pricing, sales revenue, and gross profit margin of major players in the global Botanical Drug industry. Additionally, this report provides an in-depth analysis of the market status and future development trends of different product segments of Botanical Drug and their downstream application fields.
In terms of data, this report includes a comprehensive time-series dataset. The historical data spans from 2020 to 2024, providing a solid foundation for analyzing past market trends. The year 2025 is used as a base year to accurately assess the current market landscape. Forecast data covers the period from 2026 to 2032, utilizing scientific analysis methods and models to offer forward-looking predictions and insights into the market's future development. This provides valuable reference information for industry participants and stakeholders.
The report covers regions and countries including North America, Europe, China, Asia Pacific (excluding China), Latin America, the Middle East, and Africa. It particularly focuses on the sales revenue of Botanical Drug in these regions and countries, as well as the market share of key market players in each region. The report provides an in-depth analysis of the regional distribution and future development trends of the Botanical Drug market. By considering local policies, this report evaluates the market prospects of Botanical Drug in each region and country, aiming to help companies gain a comprehensive understanding of the industry characteristics and development potential in different regions, optimize regional business layout, and develop precise market strategies to achieve global development goals.
This report places a strong emphasis on data quality and reliability, utilizing diverse and extensive data sources to ensure the accuracy and validity of the information presented. Primary data collection involves multiple channels, including in-depth interviews with senior executives, industry experts, supply chain stakeholders, and end consumers. These interviews provide key insights into corporate strategic planning, industry policy interpretation, supply chain dynamics, and end-user experiences. Secondary data sources cover a wide range of authoritative statistics from government agencies, customs databases, industry associations, third-party paid databases, brokerage research reports, academic research findings, corporate annual reports, financial statements, real-time news updates, and relevant information from international organizations. These data sources serve as a solid foundation for verification and analysis.
Companies Covered
Buchang Pharmaceuticals
China TCM
Tsumura
Schwabe
Tong Ren Tang
Jumpcan Pharmaceutical
Guangzhou Baiyunshan Pharmaceutical
Yunnan Baiyao
Tasly Holding Group
Bionorica Se
Weleda
Taiji
Huarun 999
Kwangdong
GW Pharmaceuticals
Product Segment
Prescription Drug
OTC Drug
Product Application
Cardiovascular
Tumor
Respiratory System
Others
Chapter Scope
Chapter 1: Product Statistical Scope, Product Segmentation Types and Downstream Applications, Overall Market Size, Current Status and Development Prospects
Chapter 2: Global Botanical Drug Industry Chain Analysis
Chapter 3: Global Botanical Drug Industry Environment Analysis and Porter's Five Forces Analysis
Chapter 4: Analysis of the Competitive Landscape of Major Companies in the Global Botanical Drug Market (Market Share, Product Revenue Comparison, Tier Division, Corporate Expansion and M&A Trends)
Chapter 5: Analysis of Global Major Companies (Company Profiles, Product Features and Product Segment, Product Revenue, Product Average Price, Gross Profit Margin and Geographical Sales Share)
Chapter 6: Global Botanical Drug Product Segment and Downstream Application Size Analysis and Major Regional Market Size Analysis
Chapter 7: North America Botanical Drug Product Segment, Downstream Application, and Major Countries Market Size Analysis
Chapter 8: Europe Botanical Drug Product Segment, Downstream Application, and Major Countries Market Size Analysis
Chapter 9: China Botanical Drug Product Segment, Downstream Application, and Major Countries Market Size Analysis
Chapter 10: Asia Pacific (excluding China) Botanical Drug Product Segment, Downstream Application, and Major Countries Market Size Analysis
Chapter 11: Latin America Botanical Drug Product Segment, Downstream Application, and Major Countries Market Size Analysis
Chapter 12: Middle East and Africa Botanical Drug Product Segment, Downstream Application, and Major Countries Market Size Analysis
Chapter 13: Research Conclusion
Chapter 14: Methodology and Data Source
Purpose and Value of the Report
Market Trend Insights: Analyze industry trends, market dynamics, and future growth potential to help companies forecast changes and develop strategic plans.
Competitive Landscape Analysis: Understand key players' revenue segmentation, strategies, market share, and business models to guide competitive decisions.
Investment Decision Support: Provide feasibility analysis through market size, growth rate, demand trends, and potential risks for informed investment decisions.
Target Customer and Demand Analysis: Examine consumer behavior, purchasing preferences, and pain points to optimize products and improve market penetration.
Policy and Regulatory Insights: Interpret relevant industry policies to ensure compliance and mitigate regulatory risks.
Business Model Optimization: Offer data-driven suggestions for enhancing business models and improving profitability.
Table of Contents
1 Botanical Drug Market Overview
1.1 Product Definition Introduction
1.2 Global Botanical Drug Market Size and Growth Forecast Analysis (2020-2032)
1.3 Botanical Drug Market Status and Development Prospects
1.3.1 Botanical Drug Market Status
1.3.2 Botanical Drug Industry Development Prospects
1.4 Botanical Drug Market Overview by Product Segment
1.4.1 Global Botanical Drug Market Size and Growth Forecast Analysis by Product Segment: 2020 VS 2025 VS 2032
1.4.2 Prescription Drug
1.4.3 OTC Drug
1.5 Botanical Drug Market Overview by Product Application
1.5.1 Global Botanical Drug Market Size and Growth Forecast Analysis by Product Application: 2020 VS 2025 VS 2032
1.5.2 Cardiovascular
1.5.3 Tumor
1.5.4 Respiratory System
1.5.5 Others
2 Botanical Drug Industry Supply Chain Analysis
2.1 Botanical Drug Supply Chain
2.2 Botanical Drug Midstream Suppliers
2.3 Botanical Drug Downstream Customers
2.4 Botanical Drug Sales Channel Analysis
3 Botanical Drug Market Environment Analysis
3.1 Botanical Drug Industry Policy Analysis
3.2 Botanical Drug Emerging Technology Trends in the Industry
3.3 Botanical Drug Restraining Factors Analysis
3.4 Botanical Drug Market Porter's Five Forces Analysis
3.4.1 Competitive Rivalry
3.4.2 Threat of New Entrants
3.4.3 Bargaining Power of Suppliers
3.4.4 Bargaining Power of Buyers
3.4.5 Threat of Substitute Products or Services
4 Global Botanical Drug Market Players Competition Landscape
4.1 Global Botanical Drug Market Revenue by Key Players (2021-2025)
4.2 Global Botanical Drug Market Position by Key Players
4.3 Global Key Players Headquarter and Key Area Served
4.4 Global Botanical Drug Market Expansion and M&A Dynamic
5 In-depth Analysis of Key Players
5.1 Buchang Pharmaceuticals
5.1.1 Buchang Pharmaceuticals Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.1.2 Buchang Pharmaceuticals Botanical Drug Product Features
5.1.3 Buchang Pharmaceuticals Botanical Drug Product Revenue and Gross Margin Analysis (2021-2025)
5.1.4 Buchang Pharmaceuticals Botanical Drug Revenue by Product Segment
5.1.5 Buchang Pharmaceuticals Botanical Drug Revenue by Region
5.2 China TCM
5.2.1 China TCM Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.2.2 China TCM Botanical Drug Product Features
5.2.3 China TCM Botanical Drug Product Revenue and Gross Margin Analysis (2021-2025)
5.2.4 China TCM Botanical Drug Revenue by Product Segment
5.2.5 China TCM Botanical Drug Revenue by Region
5.3 Tsumura
5.3.1 Tsumura Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.3.2 Tsumura Botanical Drug Product Features
5.3.3 Tsumura Botanical Drug Product Revenue and Gross Margin Analysis (2021-2025)
5.3.4 Tsumura Botanical Drug Revenue by Product Segment
5.3.5 Tsumura Botanical Drug Revenue by Region
5.4 Schwabe
5.4.1 Schwabe Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.4.2 Schwabe Botanical Drug Product Features
5.4.3 Schwabe Botanical Drug Product Revenue and Gross Margin Analysis (2021-2025)
5.4.4 Schwabe Botanical Drug Revenue by Product Segment
5.4.5 Schwabe Botanical Drug Revenue by Region
5.5 Tong Ren Tang
5.5.1 Tong Ren Tang Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.5.2 Tong Ren Tang Botanical Drug Product Features
5.5.3 Tong Ren Tang Botanical Drug Product Revenue and Gross Margin Analysis (2021-2025)
5.5.4 Tong Ren Tang Botanical Drug Revenue by Product Segment
5.5.5 Tong Ren Tang Botanical Drug Revenue by Region
5.6 Jumpcan Pharmaceutical
5.6.1 Jumpcan Pharmaceutical Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.6.2 Jumpcan Pharmaceutical Botanical Drug Product Features
5.6.3 Jumpcan Pharmaceutical Botanical Drug Product Revenue and Gross Margin Analysis (2021-2025)
5.6.4 Jumpcan Pharmaceutical Botanical Drug Revenue by Product Segment
5.6.5 Jumpcan Pharmaceutical Botanical Drug Revenue by Region
5.7 Guangzhou Baiyunshan Pharmaceutical
5.7.1 Guangzhou Baiyunshan Pharmaceutical Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.7.2 Guangzhou Baiyunshan Pharmaceutical Botanical Drug Product Features
5.7.3 Guangzhou Baiyunshan Pharmaceutical Botanical Drug Product Revenue and Gross Margin Analysis (2021-2025)
5.7.4 Guangzhou Baiyunshan Pharmaceutical Botanical Drug Revenue by Product Segment
5.7.5 Guangzhou Baiyunshan Pharmaceutical Botanical Drug Revenue by Region
5.8 Yunnan Baiyao
5.8.1 Yunnan Baiyao Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.8.2 Yunnan Baiyao Botanical Drug Product Features
5.8.3 Yunnan Baiyao Botanical Drug Product Revenue and Gross Margin Analysis (2021-2025)
5.8.4 Yunnan Baiyao Botanical Drug Revenue by Product Segment
5.8.5 Yunnan Baiyao Botanical Drug Revenue by Region
5.9 Tasly Holding Group
5.9.1 Tasly Holding Group Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.9.2 Tasly Holding Group Botanical Drug Product Features
5.9.3 Tasly Holding Group Botanical Drug Product Revenue and Gross Margin Analysis (2021-2025)
5.9.4 Tasly Holding Group Botanical Drug Revenue by Product Segment
5.9.5 Tasly Holding Group Botanical Drug Revenue by Region
5.10 Bionorica Se
5.10.1 Bionorica Se Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.10.2 Bionorica Se Botanical Drug Product Features
5.10.3 Bionorica Se Botanical Drug Product Revenue and Gross Margin Analysis (2021-2025)
5.10.4 Bionorica Se Botanical Drug Revenue by Product Segment
5.10.5 Bionorica Se Botanical Drug Revenue by Region
5.11 Weleda
5.11.1 Weleda Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.11.2 Weleda Botanical Drug Product Features
5.11.3 Weleda Botanical Drug Product Revenue and Gross Margin Analysis (2021-2025)
5.11.4 Weleda Botanical Drug Revenue by Product Segment
5.11.5 Weleda Botanical Drug Revenue by Region
5.12 Taiji
5.12.1 Taiji Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.12.2 Taiji Botanical Drug Product Features
5.12.3 Taiji Botanical Drug Product Revenue and Gross Margin Analysis (2021-2025)
5.12.4 Taiji Botanical Drug Revenue by Product Segment
5.12.5 Taiji Botanical Drug Revenue by Region
5.13 Huarun 999
5.13.1 Huarun 999 Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.13.2 Huarun 999 Botanical Drug Product Features
5.13.3 Huarun 999 Botanical Drug Product Revenue and Gross Margin Analysis (2021-2025)
5.13.4 Huarun 999 Botanical Drug Revenue by Product Segment
5.13.5 Huarun 999 Botanical Drug Revenue by Region
5.14 Kwangdong
5.14.1 Kwangdong Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.14.2 Kwangdong Botanical Drug Product Features
5.14.3 Kwangdong Botanical Drug Product Revenue and Gross Margin Analysis (2021-2025)
5.14.4 Kwangdong Botanical Drug Revenue by Product Segment
5.14.5 Kwangdong Botanical Drug Revenue by Region
5.15 GW Pharmaceuticals
5.15.1 GW Pharmaceuticals Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.15.2 GW Pharmaceuticals Botanical Drug Product Features
5.15.3 GW Pharmaceuticals Botanical Drug Product Revenue and Gross Margin Analysis (2021-2025)
5.15.4 GW Pharmaceuticals Botanical Drug Revenue by Product Segment
5.15.5 GW Pharmaceuticals Botanical Drug Revenue by Region
6 Global Botanical Drug Market Analysis by Regions, by Product Segment and Application
6.1 Global Botanical Drug Market Size and Growth Forecast by Region: 2020 VS 2025 VS 2032
6.1.1 Global Botanical Drug Market Revenue by Region (2020-2025)
6.1.2 Global Botanical Drug Market Revenue Forecast by Region (2026-2032)
6.2 Global Botanical Drug Market Size by Product Segment (2020-2032)
6.3 Global Botanical Drug Market Size by Product Application (2020-2032)
7 North America Botanical Drug Market Analysis
7.1 North America Botanical Drug Market Prospects
7.1.1 North America Botanical Drug Market Revenue and Growth Forecast by Countries (2020-2032)
7.1.2 U.S.
7.1.3 Canada
7.2 North America Botanical Drug Market Size by Product Segment (2020-2032)
7.3 North America Botanical Drug Market Size by Product Application (2020-2032)
8 Europe Botanical Drug Market Analysis
8.1 Europe Botanical Drug Market Prospects
8.1.1 Europe Botanical Drug Market Revenue and Growth Forecast by Countries (2020-2032)
8.1.2 Germany
8.1.3 France
8.1.4 United Kingdom
8.1.5 Italy
8.1.6 Spain
8.1.7 Benelux
8.2 Europe Botanical Drug Market Size by Product Segment (2020-2032)
8.3 Europe Botanical Drug Market Size by Product Application (2020-2032)
9 China Botanical Drug Market Analysis
9.1 China Botanical Drug Market Prospects
9.2 China Botanical Drug Market Size by Product Segment (2020-2032)
9.3 China Botanical Drug Market Size by Product Application (2020-2032)
10 Asia Pacific (excl. China) Botanical Drug Market Analysis
10.1 Asia Pacific (excl. China) Botanical Drug Market Prospects
10.1.1 Asia Pacific (excl. China) Botanical Drug Revenue and Growth Forecast by Countries (2020-2032)
10.1.2 Japan
10.1.3 South Korea
10.1.4 India
10.1.5 Southeast Asia
10.1.6 Australia
10.2 Asia Pacific (excl. China) Botanical Drug Market Size by Product Segment (2020-2032)
10.3 Asia Pacific (excl. China) Botanical Drug Market Size by Product Application (2020-2032)
11 Latin America Botanical Drug Market Analysis
11.1 Latin America Botanical Drug Market Prospects
11.1.1 Latin America Botanical Drug Revenue and Growth Forecast by Countries (2020-2032)
11.1.2 Mexico
11.1.3 Brazil
11.2 Latin America Botanical Drug Market Size by Product Segment (2020-2032)
11.3 Latin America Botanical Drug Market Size by Product Application (2020-2032)
12 Middle East and Africa Botanical Drug Market Analysis
12.1 Middle East and Africa Botanical Drug Market Prospects
12.1.1 Middle East and Africa Botanical Drug Revenue and Growth Forecast by Countries (2020-2032)
12.1.2 Saudi Arabia
12.1.3 South Africa
12.2 Middle East and Africa Botanical Drug Market Size by Product Segment (2020-2032)
12.3 Middle East and Africa Botanical Drug Market Size by Product Application (2020-2032)
13 Research Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.2 Research Landscape
14.3 Research Benchmark and Hypothesis
14.4 Data Source
14.4.1 Primary Sources
14.4.2 Secondary Sources
14.5 Data Cross Validation
14.6 Disclaimer
Table 1：Global Botanical Drug Market Size and Growth Forecast Analysis by Product Segment (2020 VS 2025 VS 2032) & (Million USD)
Table 2：Global Botanical Drug Market Size and Growth Forecast Analysis by Product Application (2020 VS 2025 VS 2032) & (Million USD)
Table 3：Botanical Drug Downstream Customers List
Table 4：Botanical Drug Distributors/Dealers List
Table 5：Global Botanical Drug Market Revenue by Key Players (2021-2025) & (Million USD)
Table 6：Global Botanical Drug Market Position by Key Players
Table 7：Global Key Players Headquarter and Key Area Served
Table 8：Global Botanical Drug Market Expansion and M&A Dynamic
Table 9：Buchang Pharmaceuticals Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 10：Buchang Pharmaceuticals Botanical Drug Product Features
Table 11：Buchang Pharmaceuticals Botanical Drug Revenue (Million USD) and Gross Margin (2021-2025)
Table 12：Buchang Pharmaceuticals Botanical Drug Revenue by Product Segment
Table 13：Buchang Pharmaceuticals Botanical Drug Revenue by Region
Table 14：China TCM Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 15：China TCM Botanical Drug Product Features
Table 16：China TCM Botanical Drug Revenue (Million USD) and Gross Margin (2021-2025)
Table 17：China TCM Botanical Drug Revenue by Product Segment
Table 18：China TCM Botanical Drug Revenue by Region
Table 19：Tsumura Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 20：Tsumura Botanical Drug Product Features
Table 21：Tsumura Botanical Drug Revenue (Million USD) and Gross Margin (2021-2025)
Table 22：Tsumura Botanical Drug Revenue by Product Segment
Table 23：Tsumura Botanical Drug Revenue by Region
Table 24：Schwabe Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 25：Schwabe Botanical Drug Product Features
Table 26：Schwabe Botanical Drug Revenue (Million USD) and Gross Margin (2021-2025)
Table 27：Schwabe Botanical Drug Revenue by Product Segment
Table 28：Schwabe Botanical Drug Revenue by Region
Table 29：Tong Ren Tang Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 30：Tong Ren Tang Botanical Drug Product Features
Table 31：Tong Ren Tang Botanical Drug Revenue (Million USD) and Gross Margin (2021-2025)
Table 32：Tong Ren Tang Botanical Drug Revenue by Product Segment
Table 33：Tong Ren Tang Botanical Drug Revenue by Region
Table 34：Jumpcan Pharmaceutical Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 35：Jumpcan Pharmaceutical Botanical Drug Product Features
Table 36：Jumpcan Pharmaceutical Botanical Drug Revenue (Million USD) and Gross Margin (2021-2025)
Table 37：Jumpcan Pharmaceutical Botanical Drug Revenue by Product Segment
Table 38：Jumpcan Pharmaceutical Botanical Drug Revenue by Region
Table 39：Guangzhou Baiyunshan Pharmaceutical Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 40：Guangzhou Baiyunshan Pharmaceutical Botanical Drug Product Features
Table 41：Guangzhou Baiyunshan Pharmaceutical Botanical Drug Revenue (Million USD) and Gross Margin (2021-2025)
Table 42：Guangzhou Baiyunshan Pharmaceutical Botanical Drug Revenue by Product Segment
Table 43：Guangzhou Baiyunshan Pharmaceutical Botanical Drug Revenue by Region
Table 44：Yunnan Baiyao Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 45：Yunnan Baiyao Botanical Drug Product Features
Table 46：Yunnan Baiyao Botanical Drug Revenue (Million USD) and Gross Margin (2021-2025)
Table 47：Yunnan Baiyao Botanical Drug Revenue by Product Segment
Table 48：Yunnan Baiyao Botanical Drug Revenue by Region
Table 49：Tasly Holding Group Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 50：Tasly Holding Group Botanical Drug Product Features
Table 51：Tasly Holding Group Botanical Drug Revenue (Million USD) and Gross Margin (2021-2025)
Table 52：Tasly Holding Group Botanical Drug Revenue by Product Segment
Table 53：Tasly Holding Group Botanical Drug Revenue by Region
Table 54：Bionorica Se Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 55：Bionorica Se Botanical Drug Product Features
Table 56：Bionorica Se Botanical Drug Revenue (Million USD) and Gross Margin (2021-2025)
Table 57：Bionorica Se Botanical Drug Revenue by Product Segment
Table 58：Bionorica Se Botanical Drug Revenue by Region
Table 59：Weleda Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 60：Weleda Botanical Drug Product Features
Table 61：Weleda Botanical Drug Revenue (Million USD) and Gross Margin (2021-2025)
Table 62：Weleda Botanical Drug Revenue by Product Segment
Table 63：Weleda Botanical Drug Revenue by Region
Table 64：Taiji Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 65：Taiji Botanical Drug Product Features
Table 66：Taiji Botanical Drug Revenue (Million USD) and Gross Margin (2021-2025)
Table 67：Taiji Botanical Drug Revenue by Product Segment
Table 68：Taiji Botanical Drug Revenue by Region
Table 69：Huarun 999 Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 70：Huarun 999 Botanical Drug Product Features
Table 71：Huarun 999 Botanical Drug Revenue (Million USD) and Gross Margin (2021-2025)
Table 72：Huarun 999 Botanical Drug Revenue by Product Segment
Table 73：Huarun 999 Botanical Drug Revenue by Region
Table 74：Kwangdong Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 75：Kwangdong Botanical Drug Product Features
Table 76：Kwangdong Botanical Drug Revenue (Million USD) and Gross Margin (2021-2025)
Table 77：Kwangdong Botanical Drug Revenue by Product Segment
Table 78：Kwangdong Botanical Drug Revenue by Region
Table 79：GW Pharmaceuticals Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 80：GW Pharmaceuticals Botanical Drug Product Features
Table 81：GW Pharmaceuticals Botanical Drug Revenue (Million USD) and Gross Margin (2021-2025)
Table 82：GW Pharmaceuticals Botanical Drug Revenue by Product Segment
Table 83：GW Pharmaceuticals Botanical Drug Revenue by Region
Table 84：Global Botanical Drug Market Size and Growth Forecast by Region (2020 VS 2025 VS 2032) & (Million USD)
Table 85：Global Botanical Drug Market Revenue by Region (2020-2025) & (Million USD)
Table 86：Global Botanical Drug Market Share by Region (2020-2025)
Table 87：Global Botanical Drug Market Revenue Forecast by Region (2026-2032) & (Million USD)
Table 88：Global Botanical Drug Market Share Forecast by Region (2026-2032)
Table 89：Global Botanical Drug Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 90：Global Botanical Drug Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 91：Global Botanical Drug Market Revenue by Product Application (2020-2025) & (Million USD)
Table 92：Global Botanical Drug Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 93：North America Botanical Drug Market Revenue by Countries (2020-2025) & (Million USD)
Table 94：North AmericaBotanical Drug Market Revenue Forecast by Countries (2026-2032) & (Million USD)
Table 95：North America Botanical Drug Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 96：North America Botanical Drug Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 97：North America Botanical Drug Market Revenue by Product Application (2020-2025) & (Million USD)
Table 98：North America Botanical Drug Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 99：Europe Botanical Drug Market Revenue by Countries (2020-2025) & (Million USD)
Table 100：Europe Botanical Drug Market Revenue Forecast by Countries (2026-2032) & (Million USD)
Table 101：Europe Botanical Drug Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 102：Europe Botanical Drug Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 103：Europe Botanical Drug Market Revenue by Product Application (2020-2025) & (Million USD)
Table 104：Europe Botanical Drug Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 105：China Botanical Drug Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 106：China Botanical Drug Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 107：China Botanical Drug Market Revenue by Product Application (2020-2025) & (Million USD)
Table 108：China Botanical Drug Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 109：Asia Pacific (excl. China) Botanical Drug Market Revenue by Countries (2020-2025) & (Million USD)
Table 110：Asia Pacific (excl. China) Botanical Drug Market Revenue Forecast by Countries (2026-2032) & (Million USD)
Table 111：Asia Pacific (excl. China) Botanical Drug Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 112：Asia Pacific (excl. China) Botanical Drug Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 113：Asia Pacific (excl. China) Botanical Drug Market Revenue by Product Application (2020-2025) & (Million USD)
Table 114：Asia Pacific (excl. China) Botanical Drug Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 115：Latin America Botanical Drug Market Revenue by Countries (2020-2025) & (Million USD)
Table 116：Latin America Botanical Drug Market Revenue Forecast by Countries (2026-2032) & (Million USD)
Table 117：Latin America Botanical Drug Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 118：Latin America Botanical Drug Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 119：Latin America Botanical Drug Market Revenue by Product Application (2020-2025) & (Million USD)
Table 120：Latin America Botanical Drug Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 121：Middle East and Africa Botanical Drug Market Revenue by Countries (2020-2025) & (Million USD)
Table 122：Middle East and Africa Botanical Drug Market Revenue Forecast by Countries (2026-2032) & (Million USD)
Table 123：Middle East and Africa Botanical Drug Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 124：Middle East and Africa Botanical Drug Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 125：Middle East and Africa Botanical Drug Market Revenue by Product Application (2020-2025) & (Million USD)
Table 126：Middle East and Africa Botanical Drug Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 127：Secondary Sources
Figure 1：Botanical Drug Product Scope
Figure 2：Global Botanical Drug Market Size and Growth Forecast Analysis (2020-2032) & (Million USD)
Figure 3：Global Botanical Drug Product Segment Market Share (2025 & 2032)
Figure 4：Global Botanical Drug Product Application Market Share (2025 & 2032)
Figure 5：Prescription Drug Product Scope
Figure 6：OTC Drug Product Scope
Figure 7：Cardiovascular Product Scope
Figure 8：Tumor Product Scope
Figure 9：Respiratory System Product Scope
Figure 10：Others Product Scope
Figure 11：Botanical Drug Industrial Chain Framework
Figure 12：Global Botanical Drug Market by Geographic Segmentation in 2025
Figure 13：Global Botanical Drug Market Share by Region (2020 VS 2025)
Figure 14：North America Botanical Drug Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 15：North America Botanical Drug Revenue Market Share by Countries (2025 VS 2032)
Figure 16：U.S. Botanical Drug Market Revenue and Forecast (2020-2032) & (Million USD)
Figure 17：Canada Botanical Drug Market Revenue and Forecast (2020-2032) & (Million USD)
Figure 18：Europe Botanical Drug Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 19：Europe Botanical Drug Revenue Market Share by Countries (2025 VS 2032)
Figure 20：Germany Botanical Drug Market Revenue and Forecast (2020-2032) & (Million USD)
Figure 21：France Botanical Drug Market Revenue and Forecast (2020-2032) & (Million USD)
Figure 22：United Kingdom Botanical Drug Market Revenue and Forecast (2020-2032) & (Million USD)
Figure 23：Italy Botanical Drug Market Revenue and Forecast (2020-2032) & (Million USD)
Figure 24：Spain Botanical Drug Market Revenue and Forecast (2020-2032) & (Million USD)
Figure 25：Benelux Botanical Drug Market Revenue and Forecast (2020-2032) & (Million USD)
Figure 26：China Botanical Drug Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 27：Asia Pacific (excl. China) Botanical Drug Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 28：Asia Pacific (excl. China) Botanical Drug Revenue Market Share by Countries (2025 VS 2032)
Figure 29：Japan Botanical Drug Market Revenue and Forecast (2020-2032) & (Million USD)
Figure 30：South Korea Botanical Drug Market Revenue and Forecast (2020-2032) & (Million USD)
Figure 31：India Botanical Drug Market Revenue and Forecast (2020-2032) & (Million USD)
Figure 32：Southeast Asia Botanical Drug Market Revenue and Forecast (2020-2032) & (Million USD)
Figure 33：Australia Botanical Drug Market Revenue and Forecast (2020-2032) & (Million USD)
Figure 34：Latin America Botanical Drug Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 35：Latin America Botanical Drug Revenue Market Share by Countries (2025 VS 2032)
Figure 36：Mexico Botanical Drug Market Revenue and Forecast (2020-2032) & (Million USD)
Figure 37：Brazil Botanical Drug Market Revenue and Forecast (2020-2032) & (Million USD)
Figure 38：Middle East and Africa Botanical Drug Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 39：Middle East and Africa Botanical Drug Revenue Market Share by Countries (2025 VS 2032)
Figure 40：Saudi Arabia Botanical Drug Market Revenue and Forecast (2020-2032) & (Million USD)
Figure 41：South Africa Botanical Drug Market Revenue and Forecast (2020-2032) & (Million USD)
Figure 42：Research Methodology
Figure 43：Primary Sources
Figure 44：Data Cross Validation
English
Related Reports 
